Search Results - "ÜRESIN, ALI YAGIZ"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Evaluation of Risk Factors Associated With Antihypertensive Treatment Success Employing Data Mining Techniques by Şen, Selçuk, Demirkol, Denizhan, Kaşkal, Mert, Gezer, Murat, Bucak, Ayşenur Yaman, Gürel, Nermin, Selalmaz, Yasemin, Erol, Çiğdem, Üresin, Ali Yağız

    “…Objective: This study aimed to evaluate the effects of potential risk factors on antihypertensive treatment success. Methods: Patients with hypertension who…”
    Get full text
    Journal Article
  5. 5

    Hypertension and valsartan by Kizilirmak, Pinar, Uresin, Ali Yagiz

    Published in Anadolu kardiyoloji dergisi : AKD (01-12-2014)
    “…Hypertension, which is pointed to be the most frequent cause of death in the World and in Turkey and defined by the World Health Organization as global health…”
    Get full text
    Journal Article
  6. 6

    Evaluation of Stress Response in Middle-Aged Male Diabetic Hypertensive Patients by Alloqi Tahirbegolli, Iliriana, Tahirbegolli, Bernard, Şen, Selçuk, Sayın, Betül, Kaşkal, Mert, Üresin, Ali Yağız

    “…Abstract Context Stress triggers a cascade of reactions that alter the organism's dynamic steady state. There is a scarcity of interventional studies that show…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Effects of Blood Pressure Lowering With Different Antihypertensive Agents on Cognitive Function and Plasma Brain-derived Neurotrophic Factor Levels: A Comparative Study by Demir, Meral, Gürol, Ali Osman, Özyiğit, Raşit Tolga, Üresin, Ali Yağz

    Published in Journal of cardiovascular pharmacology (01-06-2016)
    “…PURPOSE:Hypertension is a risk factor for cognitive impairment (CI). However, the specific effect of antihypertensive therapy on cognitive function is still…”
    Get full text
    Journal Article
  10. 10

    The future of renin inhibition by Uresin, Ali Yağiz, Baran, Elif

    Published in Türk Kardiyoloji Derneği arşivi (01-10-2009)
    “…Although antihypertensive drugs currently used provide significant decreases in blood pressure and improve clinical results, cardiovascular morbidity and…”
    Get full text
    Journal Article
  11. 11

    THE EFFECTS OF LOSARTAN AND IMMOBILIZATION STRESS ON HEART RATE VARIABILITY AND PLASMA CORTICOSTERONE LEVELS IN RATS by ÜRESIN, ALI YAGIZ, TONYALI, HÜSEYIN, KARAMÜRSEL, SACIT

    Published in International journal of neuroscience (01-03-2004)
    “…In this study, the effects of losartan, an angiotensin II receptor antagonist, on heart rate variability and the changes of plasma corticosterone levels caused…”
    Get full text
    Journal Article
  12. 12

    Evaluation of Stress Response in Middle Age Male Diabetic Hypertensive Patients by Alloqi Tahirbegolli, Iliriana, Tahirbegolli, Bernard, Şen, Selçuk, Sayın, Betül, Kaşkal, Mert, Üresin, Ali Yağız

    “…Stress triggers a cascade of reactions that alter the organism's dynamic steady state. There is a scarcity of interventional studies that show cortisol…”
    Get full text
    Journal Article
  13. 13

    Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study by Voss, Erica A., Shoaibi, Azza, Yin Hui Lai, Lana, Blacketer, Clair, Alshammari, Thamir, Makadia, Rupa, Haynes, Kevin, Sena, Anthony G., Rao, Gowtham, van Sandijk, Sebastiaan, Fraboulet, Clement, Boyer, Laurent, Le Carrour, Tanguy, Horban, Scott, Morales, Daniel R., Martínez Roldán, Jordi, Ramírez-Anguita, Juan Manuel, Mayer, Miguel A., de Wilde, Marcel, John, Luis H., Duarte-Salles, Talita, Roel, Elena, Pistillo, Andrea, Kolde, Raivo, Maljković, Filip, Denaxas, Spiros, Papez, Vaclav, Kahn, Michael G., Natarajan, Karthik, Reich, Christian, Secora, Alex, Minty, Evan P., Shah, Nigam H., Posada, Jose D., Garcia Morales, Maria Teresa, Bosca, Diego, Cadenas Juanino, Honorio, Diaz Holgado, Antonio, Pedrera Jiménez, Miguel, Serrano Balazote, Pablo, García Barrio, Noelia, Şen, Selçuk, Üresin, Ali Yağız, Erdogan, Baris, Belmans, Luc, Byttebier, Geert, Malbrain, Manu L.N.G., Dedman, Daniel J., Cuccu, Zara, Vashisht, Rohit, Butte, Atul J., Patel, Ayan, Dahm, Lisa, Han, Cora, Bu, Fan, Arshad, Faaizah, Ostropolets, Anna, Nyberg, Fredrik, Hripcsak, George, Suchard, Marc A., Prieto-Alhambra, Dani, Rijnbeek, Peter R., Schuemie, Martijn J., Ryan, Patrick B.

    Published in EClinicalMedicine (01-04-2023)
    “…Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines,…”
    Get full text
    Journal Article
  14. 14

    Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyResearch in context by Erica A. Voss, Azza Shoaibi, Lana Yin Hui Lai, Clair Blacketer, Thamir Alshammari, Rupa Makadia, Kevin Haynes, Anthony G. Sena, Gowtham Rao, Sebastiaan van Sandijk, Clement Fraboulet, Laurent Boyer, Tanguy Le Carrour, Scott Horban, Daniel R. Morales, Jordi Martínez Roldán, Juan Manuel Ramírez-Anguita, Miguel A. Mayer, Marcel de Wilde, Luis H. John, Talita Duarte-Salles, Elena Roel, Andrea Pistillo, Raivo Kolde, Filip Maljković, Spiros Denaxas, Vaclav Papez, Michael G. Kahn, Karthik Natarajan, Christian Reich, Alex Secora, Evan P. Minty, Nigam H. Shah, Jose D. Posada, Maria Teresa Garcia Morales, Diego Bosca, Honorio Cadenas Juanino, Antonio Diaz Holgado, Miguel Pedrera Jiménez, Pablo Serrano Balazote, Noelia García Barrio, Selçuk Şen, Ali Yağız Üresin, Baris Erdogan, Luc Belmans, Geert Byttebier, Manu L.N.G. Malbrain, Daniel J. Dedman, Zara Cuccu, Rohit Vashisht, Atul J. Butte, Ayan Patel, Lisa Dahm, Cora Han, Fan Bu, Faaizah Arshad, Anna Ostropolets, Fredrik Nyberg, George Hripcsak, Marc A. Suchard, Dani Prieto-Alhambra, Peter R. Rijnbeek, Martijn J. Schuemie, Patrick B. Ryan

    Published in EClinicalMedicine (01-04-2023)
    “…Background: Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with…”
    Get full text
    Journal Article